Sign in

CIK 0001385818

  • Non-accelerated filer
  • Smaller reporting company

AYTU BIOPHARMA, INC

Sign in to watch
Ticker
AYTU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
470883144
Phone
+1 720-437-6580
Business address
7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
Former names
AYTU BIOSCIENCE, INC, Rosewind CORP
  1. 4 Grant or award Director acquired 10,000 shares (grant or award)
  2. 4 Open-market buy Director bought 78,788 shares at an average $0.86 ($67,750)
  3. 4 Open-market buy Chief Executive Officer bought 55,000 shares at an average $0.89 ($48,824)
  4. 4 Conversion Director acquired 2,751,148 shares (conversion)
  5. 4 Derivatives Options or other derivatives
  6. 4 Other acquisition Director acquired 3,120,064 shares (other)
  7. 4 Grant or award Chief Financial Officer acquired 5,000 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Chief Financial Officer acquired 65,000 shares (grant or award)
  10. 4 Open-market sale Chief Financial Officer sold 3,330 shares at $0.81 ($2,711)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award Director acquired 150,000 shares (grant or award)
  14. 4 Grant or award Director acquired 200,000 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 262,500 shares (grant or award)
  16. 4 Grant or award Director acquired 150,000 shares (grant or award)
  17. 4 Grant or award Chief Executive Officer acquired 445,500 shares (grant or award)
  18. 4 Grant or award Chief Operating Officer acquired 337,500 shares (grant or award)
  19. 4 Grant or award Director acquired 150,000 shares (grant or award)
  20. 4 Open-market buy Chief Executive Officer bought 226,105 shares at $0.45 ($101,747)

Page 6 of 10 · 187 filings